Status:
COMPLETED
MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ
Lead Sponsor:
Centre Antoine Lacassagne
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-120 years
Phase:
NA
Brief Summary
RATIONALE: Diagnostic procedures, such as MRI, may help find ductal carcinoma in situ and find out how far the disease has spread. PURPOSE: This clinical trial is studying how well MRI works in asses...
Detailed Description
OBJECTIVES: Primary * Assess the contribution of MRI in accurately determining tumor size in women with ductal breast carcinoma in situ (DCIS). Secondary * Evaluate the sensitivity of MRI in detec...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of ductal breast carcinoma in situ
- Any grade disease allowed
- Unifocal disease by mammography
- No history of breast cancer
- Hormone receptor status not specified
- PATIENT CHARACTERISTICS:
- Menopausal status not specified
- WHO performance status 0-2
- Glomerular filtration rate ≥ 30 mL/min
- Not pregnant or nursing
- Fertile patients must use effective contraception
- No allergy or contraindication to contrast MRI
- No pacemaker or vascular clip
- PRIOR CONCURRENT THERAPY:
- No prior or concurrent liver transplantation
Exclusion
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00874458
Start Date
April 1 2007
End Date
December 1 2013
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Antoine Lacassagne
Nice, France, 06189